Tag Archives: Drug Discovery & Development

3 Drug Development Principles for Smart SMEs

Robert Thong's SciTechStrategy Blog Posted on by

I was inspired to post this article after someone said to me, “The drug development skills learnt in big pharma translate naturally to the biotech world … you just have a smaller budget”. While the technical skills are essentially the same, I feel strongly that the context and mindset in which they are applied are fundamentally different. This article highlights three ways in which “smart” small/medium-sized enterprises (SMEs) conduct drug development.

Continue reading →

The Productivity Trio in Bioscience R&D

Robert Thong's SciTechStrategy Blog Posted on by

Triggered by recently published studies on R&D performance, I have engaged in some interesting discussions over the past few weeks on where to focus productivity improvement efforts. Here in one contiguous article is my take on the key levers for improving productivity in a bioscience R&D organization. … Continue reading →

BioPharma R&D Focus Paradigms when Payers are the Customers

Robert Thong's SciTechStrategy Blog Posted on by

Most Pharma companies focus their R&D activities by therapeutic area. But in the New Pharma world of Payers as Customers, does this continue to make sense? In this article, we will look at the history and evolution of therepautic area focus in R&D, highlight today’s new requirements and suggest a pragmatic … Continue reading →

Two Decades of Biomedical R&D Improvement Initiatives

Robert Thong's SciTechStrategy Blog Posted on by

Throughout the past two decades, biomedical companies have learnt painfully that industrialized management of R&D does not deliver. Using illustrations from the pharmaceutical sector, this article looks back on the principal approaches that were adopted to transform R&D productivity over this period. We reflect on what has definitely not worked … Continue reading →